| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |